Cui Q - Search Results

1

Structural basis of nanobodies neutralizing SARS-CoV-2 variants.

Shi Z, Li X, Wang L, Sun Z, Zhang H, Chen X, Cui Q, Qiao H, Lan Z, Zhang X, Li X, Li L, Xu J, Gong R, Fan C, Geng Y. Shi Z, et al. Among authors: cui q. Structure. 2022 May 5;30(5):707-720.e5. doi: 10.1016/j.str.2022.02.011. Epub 2022 Mar 10. Structure. 2022. PMID: 35276082 Free PMC article.

2

Structural insights into the activation of human calcium-sensing receptor.

Chen X, Wang L, Cui Q, Ding Z, Han L, Kou Y, Zhang W, Wang H, Jia X, Dai M, Shi Z, Li Y, Li X, Geng Y. Chen X, et al. Among authors: cui q. Elife. 2021 Sep 1;10:e68578. doi: 10.7554/eLife.68578. Elife. 2021. PMID: 34467854 Free PMC article.

3

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.

Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, Huang W, Li Q, Wang P, An R, Wang J, Wang Y, Niu X, Yang S, Liang H, Sun H, Li T, Yu Y, Cui Q, Liu S, Yang X, Du S, Zhang Z, Hao X, Shao F, Jin R, Wang X, Xiao J, Wang Y, Xie XS. Cao Y, et al. Among authors: cui q. Nature. 2022 Feb;602(7898):657-663. doi: 10.1038/s41586-021-04385-3. Epub 2021 Dec 23. Nature. 2022. PMID: 35016194 Free PMC article.

4

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses.

Li Q, Zhang L, Liang Z, Wang N, Liu S, Li T, Yu Y, Cui Q, Wu X, Nie J, Wu J, Cui Z, Lu Q, Wang X, Huang W, Wang Y. Li Q, et al. Among authors: cui q, cui z. Signal Transduct Target Ther. 2022 Jul 27;7(1):256. doi: 10.1038/s41392-022-01123-7. Signal Transduct Target Ther. 2022. PMID: 35896529 Free PMC article.

5

Structure basis of two nanobodies neutralizing SARS-CoV-2 Omicron variant by targeting ultra-conservative epitopes.

Sun Z, Wang L, Li L, Sun Y, Zhang D, Zhou S, Li Y, Li X, Qiao H, Cui Q, Lan Z, Meng X, Xu J, Geng Y, Dai Y. Sun Z, et al. Among authors: cui q. J Struct Biol. 2023 Sep;215(3):107996. doi: 10.1016/j.jsb.2023.107996. Epub 2023 Jul 5. J Struct Biol. 2023. PMID: 37419228

6

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.

Zhang L, Li Q, Liang Z, Li T, Liu S, Cui Q, Nie J, Wu Q, Qu X, Huang W, Wang Y. Zhang L, et al. Among authors: cui q. Emerg Microbes Infect. 2022 Dec;11(1):1-5. doi: 10.1080/22221751.2021.2017757. Emerg Microbes Infect. 2022. PMID: 34890524 Free PMC article.

7

Antigenicity comparison of SARS-CoV-2 Omicron sublineages with other variants contained multiple mutations in RBD.

Li Q, Zhang M, Liang Z, Zhang L, Wu X, Yang C, An Y, Tong J, Liu S, Li T, Cui Q, Nie J, Wu J, Huang W, Wang Y. Li Q, et al. Among authors: cui q. MedComm (2020). 2022 Apr 9;3(2):e130. doi: 10.1002/mco2.130. eCollection 2022 Jun. MedComm (2020). 2022. PMID: 35434713 Free PMC article.

8

Smoke and Spike: Benzo[a]pyrene Enhances SARS-CoV-2 Infection by Boosting NR4A2-Induced ACE2 and TMPRSS2 Expression.

Liu W, Zhao Y, Fan J, Shen J, Tang H, Tang W, Wu D, Huang W, Ding Y, Qiao P, Lin J, Li Z, Li Q, Cui Q, Liu Y, Chen Y, Pu R, Han X, Yin J, Tan X, Cao G. Liu W, et al. Among authors: cui q. Adv Sci (Weinh). 2023 Sep;10(26):e2300834. doi: 10.1002/advs.202300834. Epub 2023 Jul 10. Adv Sci (Weinh). 2023. PMID: 37428471 Free PMC article.

9

Long-term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac-inactivated booster: A 7-month follow-up study.

Li X, Yin Y, Cui Q, Huang W, Zou Q, Shen T. Li X, et al. Among authors: cui q. J Med Virol. 2023 Jan;95(1):e28279. doi: 10.1002/jmv.28279. Epub 2022 Nov 11. J Med Virol. 2023. PMID: 36329634 Free PMC article.

10

Application of Pseudotyped Viruses.

Cui Q, Huang W. Cui Q, et al. Adv Exp Med Biol. 2023;1407:45-60. doi: 10.1007/978-981-99-0113-5_3. Adv Exp Med Biol. 2023. PMID: 36920691 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,859 results

Search Page